Statistics for Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
Total visits
| views | |
|---|---|
| Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis | 3 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 1 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:4c3a868a-ecbb-4518-b5f1-93d5e1d78eda | 38 |
| java.util.UUID:8460100e-d380-4d56-af91-759fac1d9733 | 11 |
| java.util.UUID:62531dea-674b-42ef-aa02-e498ad82109c | 6 |
| Rossing2022Finerenone-AAM.pdf | 5 |
Top country views
| views | |
|---|---|
| United States | 3 |
Top city views
| views | |
|---|---|
| Franklin | 2 |
| Indianapolis | 1 |